Pharmaceutical News and Articles

Celltrion Announces U.S. FDA Approval of Additional Presentation of Steqeyma (ustekinumab-stba), Expanding Dosing Options for Pediatric Patients

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attac

FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk

offering the potential to boost PrEP uptake and persistence and adding a powerful new tool in our mission to end the HIV epidemic, Carlos del Rio, M.D., from Em

Dementia Caregivers Have Modifiable Risk Factors Increasing Their Own Risk

Six in 10 dementia caregivers report having at least one modifiable risk factor that could increase their own chances of developing dementia, according to a rep

HIV Drug, Lamivudine, Potentially Effective Against Diabetic Eye Disease

FRIDAY, June 20, 2025 A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new small-scale study say

FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo

FRIDAY, June 20, 2025 A new shot to prevent HIV infection has just been approved and it only needs to be taken twice a year. On Wednesday, the U.S. Food and Dru

Trump Administration To End Lifeline for LGBTQ+ Youth This July

FRIDAY, June 20, 2025 A popular crisis support line for LGBTQ youth and young adults is shutting down July 17, federal officials confirmed this week. The Press

Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma

Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study published online June 18 in JAMA Ophthalmo

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published recently i

Metabolic Dysfunction-Associated Steatotic Liver Disease Linked to Risk for Sudden Hearing Loss

Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for sudden sensorineural hearing loss (SS